Lídia Robert - Concepedia

Author

Lídia Robert

University of California, Los Angeles

Also Known As

Lidia Robert, Lídia Robert, Robert, L.S. Perry

Publications

12.9K

Citations

H-Index

Concepts

All Affiliations

University of California, Los Angeles UCLA Jonsson Comprehensive Cancer Center Institute for Molecular Medicine California Institute of Technology Merck & Co., Inc., Rahway, NJ, USA (United States)

About

Lídia Robert is an author at University of California, Los Angeles specializing in medicine, immunotherapy, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	8.5K
2	Cell Biology	4	4	1.9K
3	Health Sciences	1	1	57
4	Allergy	1	1	91
5	Cellular Therapies	1	1	311

Lídia Robert

Publications

12.2K

Citations

H-Index

Page 1

	Year	Citations
PD-1 blockade induces responses by inhibiting adaptive immune resistance Paul C. Tumeh, Christina L. Harview, Jennifer H. Yearley, Nature MedicineImmunologyTumor ImmunityAutoimmunityImmunomodulation	2014	6.5K
<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors Fei Su, Amaya Virós, Carla Milagre, New England Journal of Medicine	2012	1K
Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress Jennifer Tsoi, Lídia Robert, Kim H.T. Paraiso, Cancer Cell Tumor BiologyDifferential VulnerabilityPhotocarcinogenesisMelanomaDermatology	2018	909
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma Judith M. Müller, Oscar Krijgsman, Jennifer Tsoi, Nature Communications Tumor BiologyOncologyMedicineMelanomaLow Mitf/axl Ratio	2014	621
Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in <i>BRAF</i> <sup> <i>V600E</i> </sup> melanoma Siwen Hu‐Lieskovan, Stephen Mok, Blanca Homet Moreno, Science Translational Medicine	2015	562
CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire Lídia Robert, Jennifer Tsoi, Xiaoyan Wang, Clinical Cancer Research	2014	366
Effects of MAPK and PI3K Pathways on PD-L1 Expression in Melanoma Mohammad Atefi, Earl Avramis, Amanda Lassen, Clinical Cancer Research	2014	325
Inhibition of CSF-1 Receptor Improves the Antitumor Efficacy of Adoptive Cell Transfer Immunotherapy Stephen Mok, Richard C. Koya, Christopher Tsui, Cancer Research Cell TherapyTyrosine KinaseImmunologyImmune RegulationAntitumor Efficacy	2013	311
Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistance Yapeng Su, Wei Wei, Lídia Robert, Proceedings of the National Academy of Sciences	2017	244
MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cells Diego Ploper, Vincent Taelman, Lídia Robert, Proceedings of the National Academy of Sciences	2015	221

Page 1